Applicability of Mesenchymal Stem Cell-Derived Exosomes as a Cell-Free miRNA Therapy and Epigenetic Modifiers for Diabetes

References

• Dilworth L , FaceyA , OmoruyiF. Diabetes mellitus and its metabolic complications: the role of adipose tissues. Int. J. Mol. Sci.22(14), 7644 (2021).
   PubMed Web of Science ®Google Scholar
• https://diabetesatlas.org. Tenth Edition (2021).
   Google Scholar
• Zang L , HaoH , LiuJet al. Mesenchymal stem cell therapy in Type 2 diabetes mellitus. Diabetol. Metab. Syndr.9, 36 (2017).
   PubMed Web of Science ®Google Scholar
• Gao S , ZhangY , LiangKet al. Mesenchymal stem cells (MSCs): a novel therapy for Type 2 diabetes. Stem Cells Int.2022, 8637493 (2022).
   PubMed Web of Science ®Google Scholar
• Zhong F , JiangY. Endogenous pancreatic β cell regeneration: a potential strategy for the recovery of β cell deficiency in diabetes. Front. Endocrinol. (Lausanne)10, 101 (2019).
   PubMed Web of Science ®Google Scholar
• www.clinicaltrials.gov
   Google Scholar
• Huang Q , HuangY , LiuJ. Mesenchymal stem cells: an excellent candidate for the treatment of diabetes mellitus. Int. J. Endocrinol.2021, 9938658 (2021).
   PubMed Web of Science ®Google Scholar
• Yang M , ChenJ , ChenL. The roles of mesenchymal stem cell-derived exosomes in diabetes mellitus and its related complications. Front. Endocrinol. (Lausanne)13, 1027686 (2022).
   PubMed Web of Science ®Google Scholar
• Ling C , RönnT. Epigenetics in human obesity and Type 2 diabetes. Cell Metab.29(5), 1028–1044 (2019).
   PubMed Web of Science ®Google Scholar
• Sha K , BoyerLA. The chromatin signature of pluripotent cells. In: StemBook.Harvard Stem Cell Institute, Cambridge, MA, USA, PMID:20614601 (2008).
   Google Scholar
• Podobinska M , Szablowska-GadomskaI , AugustyniakJet al. Epigenetic modulation of stem cells in neurodevelopment: the role of methylation and acetylation. Front. Cell Neurosci.11, 23 (2017).
   PubMed Web of Science ®Google Scholar
• Anastasiadi D , Esteve-CodinaA , PiferrerF. Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species. Epigenetics Chromatin11, 37 (2018).
   PubMed Web of Science ®Google Scholar
• Walter M , TeissandierA , Pérez-PalaciosRet al. An epigenetic switch ensures transposon repression upon dynamic loss of DNA methylation in embryonic stem cells. Elife.5, e11418 (2016).
   PubMed Web of Science ®Google Scholar
• Buitrago D , LabradorM , ArconJPet al. Impact of DNA methylation on 3D genome structure. Nat. Commun.12, 3243 (2021).
   PubMed Web of Science ®Google Scholar
• Carlund O , NorbergA , OstermanPet al. DNA methylation variations and epigenetic aging in telomere biology disorders. Sci. Rep.13, 7955 (2023).
   PubMed Web of Science ®Google Scholar
• SanMiguel JM , BartolomeiMS. DNA methylation dynamics of genomic imprinting in mouse development. Biol. Reprod.99(1), 252–262 (2018).
   PubMed Web of Science ®Google Scholar
• Duncan CG , GrimmSA , MorganDLet al. Dosage compensation and DNA methylation landscape of the X chromosome in mouse liver. Sci. Rep.8, 10138 (2018).
   PubMed Web of Science ®Google Scholar
• Loaeza-Loaeza J , BeltranAS , Hernández-SoteloD. DNMTs and impact of CpG content, transcription factors, consensus motifs, lncRNAs, and histone marks on DNA methylation. Genes (Basel)11(11), 1336 (2020).
   PubMed Web of Science ®Google Scholar
• Chapman C , MarianiC , WuFet al. TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer. Sci. Rep.5, 17568 (2015).
   PubMed Web of Science ®Google Scholar
• Saxonov S , BergP , BrutlagDL. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc. Natl Acad. Sci. USA103(5), 1412–1417 (2006).
   PubMed Web of Science ®Google Scholar
• Bannister AJ , KouzaridesT. Regulation of chromatin by histone modifications. Cell Res.21(3), 381–395 (2011).
   PubMed Web of Science ®Google Scholar
• Li D , ZhangL , HeYet al. Novel histone post-translational modifications in diabetes and complications of diabetes: the underlying mechanisms and implications. Biomed. Pharmacother.156, 113984 (2022).
   PubMed Web of Science ®Google Scholar
• Petrovič D , NguyenQD , PeterlinBet al. Omics technologies and neovascular ocular disorders. Biomed. Res. Int.2014, 231348 (2014).
   PubMed Web of Science ®Google Scholar
• Keating ST , PlutzkyJ , El-OstaA. Epigenetic changes in diabetes and cardiovascular risk. Circ. Res.118(11), 1706–1722 (2016).
   PubMed Web of Science ®Google Scholar
• Natalicchio A , MontagnaniM , GalloMet al. miRNA dysregulation underlying common pathways in Type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view. ESMO Open8(3), 101573 (2023).
   PubMed Web of Science ®Google Scholar
• Bhat SS , JarmolowskiA , Szweykowska-KulińskaZ. MicroRNA biogenesis: epigenetic modifications as another layer of complexity in the microRNA expression regulation. Acta Biochim. Pol.63(4), 717–723 (2016).
   PubMed Web of Science ®Google Scholar
• Ling C , GuerraDel S , LupiRet al. Epigenetic regulation of PPARGC1A in human Type 2 diabetic islets and effect on insulin secretion. Diabetologia51(4), 615–622 (2008).
   PubMed Web of Science ®Google Scholar
• Barrès R , OslerME , YanJet al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab.10(3), 189–198 (2009).
   PubMed Web of Science ®Google Scholar
• Hall E , DayehT , KirkpatrickCLet al. DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets. BMC Med. Genet.14, 76 (2013).
   PubMed Web of Science ®Google Scholar
• Yang BT , DayehTA , KirkpatrickCLet al. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia54(2), 360–367 (2011).
   PubMed Web of Science ®Google Scholar
• Yang BT , DayehTA , VolkovPAet al. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with Type 2 diabetes. Mol. Endocrinol.26(7), 1203–1212 (2012).
   PubMedGoogle Scholar
• Dayeh T , VolkovP , SalöSet al. Genome-wide DNA methylation analysis of human pancreatic islets from Type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet.10(3), e1004160 (2014).
   PubMed Web of Science ®Google Scholar
• Volkmar M , DedeurwaerderS , CunhaDAet al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from Type 2 diabetic patients. EMBO J.31(6), 1405–1426 (2012).
   PubMed Web of Science ®Google Scholar
• Volkov P , BacosK , OforiJKet al. Whole-genome bisulfite sequencing of human pancreatic islets reveals novel differentially methylated regions in Type 2 diabetes pathogenesis. Diabetes66(4), 1074–1085 (2017).
   PubMed Web of Science ®Google Scholar
• Domingo-Relloso A , GribbleMO , Riffo-CamposALet al. Epigenetics of Type 2 diabetes and diabetes-related outcomes in the Strong Heart Study. Clin. Epigenetics14(1), 177 (2022).
   PubMed Web of Science ®Google Scholar
• Baca P , Barajas-OlmosF , MirzaeicheshmehEet al. DNA methylation and gene expression analysis in adipose tissue to identify new loci associated with T2D development in obesity. Nutr. Diabetes12(1), 50 (2022).
   PubMed Web of Science ®Google Scholar
• Fragoso-Bargas N , ElliottHR , Lee-ØdegårdSet al. Cross-ancestry DNA methylation marks of insulin resistance in pregnancy: an integrative epigenome wide association study. Diabetes72(3), 415–426 (2023).
   PubMed Web of Science ®Google Scholar
• Ouni M , EichelmannF , JähnertMet al. Differences in DNA methylation of HAMP in blood cells predicts the development of Type 2 diabetes. Mol. Metab.75, 101774 (2023).
   PubMed Web of Science ®Google Scholar
• Juvinao-Quintero DL , SharpGC , SandersonECMet al. Investigating causality in the association between DNA methylation and Type 2 diabetes using bidirectional two-sample Mendelian randomisation. Diabetologia66(7), 1247–1259 (2023).
   PubMed Web of Science ®Google Scholar
• Wang X , LiuJ , WangQ , ChenQ. The transcriptomic and epigenetic alterations in Type 2 diabetes mellitus patients of Chinese Tibetan and Han populations. Front. Endocrinol. (Lausanne)14, 1122047 (2023).
   PubMed Web of Science ®Google Scholar
• Kim H , BaeJH , ParkKSet al. DNA methylation changes associated with Type 2 diabetes and diabetic kidney disease in an East Asian Population. J. Clin. Endocrinol. Metab.106(10), e3837–e3851 (2021).
   PubMed Web of Science ®Google Scholar
• García-Calzón S , SchraderS , PerfilyevAet al. DNA methylation partially mediates antidiabetic effects of metformin on HbA1c levels in individuals with Type 2 diabetes. Diabetes Res. Clin. Pract.202, 110807 (2023).
   PubMed Web of Science ®Google Scholar
• Tu P , LiX , MaBet al. Liver histone H3 methylation and acetylation may associate withTtype 2 diabetes development. J. Physiol. Biochem.71(1), 89–98 (2015).
   PubMed Web of Science ®Google Scholar
• Jufvas A , SjödinS , LundqvistKet al. Global differences in specific histone H3 methylation are associated with overweight and Type 2 diabetes. Clin. Epigenetics5(1), 15 (2013).
   PubMedGoogle Scholar
• Lu TT , HeyneS , DrorEet al. The polycomb-dependent epigenome controls β cell dysfunction, dedifferentiation, and diabetes. Cell. Metab.27(6), 1294–1308.e7 (2018).
   PubMed Web of Science ®Google Scholar
• Vanderkruk B , MaeshimaN , PasulaDJet al. Methylation of histone H3 lysine 4 is required for maintenance of beta cell function in adult mice. Diabetologia66(6), 1097–1115 (2023).
   PubMed Web of Science ®Google Scholar
• Michael J , FowlerMD. Microvascular and macrovascular complications of diabetes. Clin. Diabetes26(2), 77–82 (2008).
   Google Scholar
• Liu DD , ZhangCY , ZhangJTet al. Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface. Neural. Regen. Res.18(7), 1441–1449 (2023).
   PubMed Web of Science ®Google Scholar
• Zhao L , XuH , LiuXet al. The role of TET2-mediated ROBO4 hypomethylation in the development of diabetic retinopathy. J. Transl. Med.21(1), 455 (2023).
   PubMed Web of Science ®Google Scholar
• Li Y , GongC , XuYet al. Genetic regulation of THBS1 methylation in diabetic retinopathy. Front. Endocrinol. (Lausanne)13, 991803 (2022).
   PubMed Web of Science ®Google Scholar
• He Y , DanY , GaoXet al. DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial–mesenchymal transition in diabetic retinopathy through the PI3K/Akt/mTOR signaling pathway. Am. J. Physiol. Endocrinol. Metab.320(3), e598–e608 (2021).
   PubMed Web of Science ®Google Scholar
• Xi X , WangM , ChenQet al. DNMT1 regulates miR-20a/TXNIP-mediated pyroptosis of retinal pigment epithelial cells through DNA methylation. Mol. Cell. Endocrinol.577, 112012 (2023).
   PubMed Web of Science ®Google Scholar
• Muramatsu D , KimuraH , KotoshibaKet al. Pericentric H3K9me3 formation by HP1 interaction-defective histone methyltransferase Suv39h1. Cell Struct. Funct.41(2), 145–152 (2016).
   PubMed Web of Science ®Google Scholar
• Bertoluci MC , RochaVZ. Cardiovascular risk assessment in patients with diabetes. Diabetol. Metab. Syndr.9, 25 (2017).
   PubMed Web of Science ®Google Scholar
• Petrie JR , GuzikTJ , TouyzRM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can. J. Cardiol.34(5), 575–584 (2018).
   PubMed Web of Science ®Google Scholar
• Keating ST , PlutzkyJ , El-OstaA. Epigenetic changes in diabetes and cardiovascular risk. Circ. Res.118, 1706–1722 (2016).
   PubMed Web of Science ®Google Scholar
• Balakrishnan A , GuruprasadKP , SatyamoorthyKet al. Interleukin-6 determines protein stabilization of DNA methyltransferases and alters DNA promoter methylation of genes associated with insulin signaling and angiogenesis. Lab. Invest.98(9), 1143–1158 (2018).
   PubMed Web of Science ®Google Scholar
• Pepin ME , SchianoC , MiceliMet al. The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia. Exp. Cell Res.400(2), 112485 (2021).
   PubMed Web of Science ®Google Scholar
• Biswas S , FengB , ThomasAet al. Endothelin-1 regulation is entangled in a complex web of epigenetic mechanisms in diabetes. Physiol. Res.67(1), S115–S125 (2018).
   PubMedGoogle Scholar
• Liao Y , GouL , ChenLet al. NADPH oxidase 4 and endothelial nitric oxide synthase contribute to endothelial dysfunction mediated by histone methylations in metabolic memory. Free Radic. Biol. Med.115, 383–394 (2018).
   PubMed Web of Science ®Google Scholar
• Paneni F , CostantinoS , BattistaRet al. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with Type 2 diabetes mellitus. Circ. Cardiovasc. Genet.8(1), 150–158 (2015).
   PubMedGoogle Scholar
• Mota-Zamorano S , GonzálezLM , RoblesNRet al. A custom target next-generation sequencing 70-gene panel and replication study to identify genetic markers of diabetic kidney disease. Genes (Basel)12(12), 1992 (2021).
   PubMed Web of Science ®Google Scholar
• Li X , LuL , HouWet al. Epigenetics in the pathogenesis of diabetic nephropathy. Acta Biochim. Biophys. Sin. (Shanghai)54(2), 163–172 (2022).
   PubMed Web of Science ®Google Scholar
• Marumo T , YagiS , KawarazakiWet al. Diabetes induces aberrant DNA methylation in the proximal tubules of the kidney. J. Am. Soc. Nephrol.26(10), 2388–2397 (2015).
   PubMed Web of Science ®Google Scholar
• Li X , LiaoJ , GuoZ. Detection value of FOXO1 gene methylation, blood glucose and lipids in patients with Type 2 diabetic kidney disease. Medicine (Baltimore)101(49), e31663 (2022).
   PubMed Web of Science ®Google Scholar
• Li KY , TamCHT , LiuHet al. DNA methylation markers for kidney function and progression of diabetic kidney disease. Nat. Commun.14(1), 2543 (2023).
   PubMed Web of Science ®Google Scholar
• Chen H , HuangY , ZhuXet al. Histone demethylase UTX is a therapeutic target for diabetic kidney disease. J. Physiol.597(6), 1643–1660 (2019).
   PubMed Web of Science ®Google Scholar
• Hung PH , HsuYC , ChenTHet al. The histone demethylase inhibitor GSK-J4 is a therapeutic target for the kidney fibrosis of diabetic kidney disease via DKK1 modulation. Int. J. Mol. Sci.23(16), 9407 (2022).
   PubMed Web of Science ®Google Scholar
• Lu L , LiX , ZhongZet al. KMT5A downregulation participated in high glucose-mediated EndMT via upregulation of ENO1 expression in diabetic nephropathy. Int. J. Biol. Sci.17(15), 4093–4107 (2021).
   PubMed Web of Science ®Google Scholar
• Wang F , HouW , LiXet al. SETD8 cooperates with MZF1 to participate in hyperglycemia-induced endothelial inflammation via elevation of WNT5A levels in diabetic nephropathy. Cell. Mol. Biol. Lett.27(1), 30 (2022).
   PubMed Web of Science ®Google Scholar
• Jia Y , ReddyMA , DasSet al. Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1-induced gene expression in mesangial cells and diabetic kidney. J. Biol. Chem.294(34), 12695–12707 (2019).
   PubMed Web of Science ®Google Scholar
• Cheng Y , ChenY , WangGet al. Protein methylation in diabetic kidney disease. Front. Med. (Lausanne)9, 736006 (2022).
   PubMed Web of Science ®Google Scholar
• Fan Y , FanH , LiPet al. Mitogen-activating protein kinase kinase kinase kinase-3, inhibited by astragaloside IV through H3 lysine 4 monomethylation, promotes the progression of diabetic nephropathy by inducing apoptosis. Bioengineered13(5), 11517–11529 (2022).
   PubMed Web of Science ®Google Scholar
• Feng J , XingW , XieL. Regulatory roles of microRNAs in diabetes. Int. J. Mol. Sci.17(10), 1729 (2016).
   PubMed Web of Science ®Google Scholar
• Deng J , GuoF. MicroRNAs and Type 2 diabetes. ExRNA1, 36 (2019).
   Google Scholar
• Benko J , SarlinovaM , MikusovaVet al. miR-126 and miR-146a as markers of Type 2 diabetes mellitus: a pilot study. Bratisl. Lek. Listy124(7), 527–533 (2023).
   PubMed Web of Science ®Google Scholar
• Taylor HJ , HungYH , NarisuNet al. Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis. Proc. Natl Acad. Sci. USA120(7), e2206797120 (2023).
   PubMedGoogle Scholar
• Cheung R , PizzaG , ChabosseauPet al. Glucose-dependent miR-125b is a negative regulator of β-cell function. Diabetes71(7), 1525–1545 (2022).
   PubMed Web of Science ®Google Scholar
• Wang Y , ZhouF , LiMet al. miR-34a-5p promotes hepatic gluconeogenesis by suppressing SIRT1 expression. Exp. Cell Res.420(1), 113336 (2022).
   PubMed Web of Science ®Google Scholar
• Lu H , YangJ , LiJet al. iR-190 ameliorates glucotoxicity-induced dysfunction and apoptosis of pancreatic β-cells by inhibiting NOX2-mediated reactive oxygen species production. PeerJ10, e13849 (2022).
   PubMed Web of Science ®Google Scholar
• Chen X , TianF , SunZet al. Elevation of circulating miR-210 participates in the occurrence and development of Type 2 diabetes mellitus and its complications. J. Diabetes Res.2022, 9611509 (2022).
   PubMed Web of Science ®Google Scholar
• Barutta F , BelliniS , MastrocolaRet al. MicroRNA and microvascular complications of diabetes. Int. J. Endocrinol.2018, 6890501 (2018).
   PubMed Web of Science ®Google Scholar
• Wu JH , WangYH , WangWet al. miR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways. Int. J. Biochem. Cell Biol.73, 41–52 (2016).
   PubMed Web of Science ®Google Scholar
• Jin J , WangX , ZhiX , MengD. Epigenetic regulation in diabetic vascular complications. J. Mol. Endocrinol.63(4), R103–R115 (2019).
   PubMed Web of Science ®Google Scholar
• Zhao S , LiT , LiJet al. miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway. Diabetologia59(3), 644–654 (2016).
   PubMed Web of Science ®Google Scholar
• Feng B , LiuJ , WangEet al. Endothelial derived miRNA-9 mediated cardiac fibrosis in diabetes and its regulation by ZFAS1. PLoS One17(10), e0276076 (2022).
   PubMed Web of Science ®Google Scholar
• Wu H , KongL , ZhouSet al. The role of microRNAs in diabetic nephropathy. J. Diabetes Res.2014, 920134 (2014).
   PubMed Web of Science ®Google Scholar
• Lu Z , LiuN , WangF. Epigenetic regulations in diabetic nephropathy. J. Diabetes Res.2017, 7805058 (2017).
   PubMed Web of Science ®Google Scholar
• Zhong X , ChungAC , ChenHYet al. miR-21 is a key therapeutic target for renal injury in a mouse model of Type 2 diabetes. Diabetologia56(3), 663–674 (2013).
   PubMed Web of Science ®Google Scholar
• Tsai YC , KuoMC , HungWWet al. Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer. Cell. Commun. Signal.21(1), 10 (2023).
   PubMed Web of Science ®Google Scholar
• Wang J , TaoY , ZhaoFet al. Expression of urinary exosomal miRNA-615-3p and miRNA-3147 in diabetic kidney disease and their association with inflammation and fibrosis. Ren. Fail.45(1), 2121929 (2023).
   PubMed Web of Science ®Google Scholar
• Caplan AI , DennisJE. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem.98(5), 1076–1084 (2006).
   PubMed Web of Science ®Google Scholar
• Hu J , WangY , GongHet al. Long term effect and safety of Wharton’s jelly-derived mesenchymal stem cells on Type 2 diabetes. Exp. Ther. Med.12(3), 1857–1866 (2016).
   PubMed Web of Science ®Google Scholar
• Zang L , LiY , HaoHet al. Efficacy of umbilical cord-derived mesenchymal stem cells in the treatment of type 2 diabetes assessed by retrospective continuous glucose monitoring. Stem Cells Transl Med. doi: 10.1093/stcltm/szad060 (2023) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Skyler JS , FonsecaVA , SegalKRet al. Allogeneic mesenchymal precursor cells in Type 2 diabetes: a randomized, placebo-controlled, dose-escalation safety and tolerability pilot study. Diabetes Care38(9), 1742–1749 (2015).
   PubMed Web of Science ®Google Scholar
• Li H , ZhuH , GeTet al. Mesenchymal stem cell-based therapy for diabetes mellitus: enhancement strategies and future perspectives. Stem. Cell Rev. Rep.17(5), 1552–1569 (2021).
   PubMed Web of Science ®Google Scholar
• Gao X , SongL , ShenKet al. Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions. Mol. Cell. Endocrinol.388(1–2), 41–50 (2014).
   PubMed Web of Science ®Google Scholar
• Sun Y , ShiH , YinSet al. Human mesenchymal stem cell derived exosomes alleviate Type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving β-cell destruction. ACS Nano12(8), 7613–7628 (2018).
   PubMed Web of Science ®Google Scholar
• Chen MT , ZhaoYT , ZhouLYet al. Exosomes derived from human umbilical cord mesenchymal stem cells enhance insulin sensitivity in insulin resistant human adipocytes. Curr. Med. Sci.41(1), 87–93 (2021).
   PubMed Web of Science ®Google Scholar
• Yap SK , TanKL , AbdRahaman NYet al. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorated insulin resistance in Type 2 diabetes mellitus rats. Pharmaceutics14(3), 649 (2022).
   PubMed Web of Science ®Google Scholar
• Xiong J , HuH , GuoRet al. Mesenchymal stem cell exosomes as a new strategy for the treatment of diabetes complications. Front. Endocrinol. (Lausanne)12, 646233 (2021).
   PubMed Web of Science ®Google Scholar
• Xiang E , HanB , ZhangQet al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res. Ther.11(1), 336 (2020).
   PubMed Web of Science ®Google Scholar
• Wang Y , LiuJ , WangHet al. Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through the NLRP3 signaling pathway. Stem Cells41(4), 368–383 (2023).
   PubMed Web of Science ®Google Scholar
• Nagaishi K , MizueY , ChikenjiTet al. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci. Rep.6, 34842 (2016).
   PubMed Web of Science ®Google Scholar
• Li H , RongP , MaXet al. Mouse umbilical cord mesenchymal stem cell paracrine alleviates renal fibrosis in diabetic nephropathy by reducing myofibroblast transdifferentiation and cell proliferation and upregulating MMPs in mesangial cells. J. Diabetes Res.2020, 3847171 (2020).
   PubMed Web of Science ®Google Scholar
• Lin Y , ZhangF , LianXFet al. Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-β1/Smad2 signaling pathway. Cell Mol. Biol. (Noisy-le-grand)65(7), 123–126 (2019).
   PubMed Web of Science ®Google Scholar
• Yin K , WangS , ZhaoRC. Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomark Res.7, 8 (2019).
   PubMed Web of Science ®Google Scholar
• Testa R , BonfigliAR , PrattichizzoF , LaSala L , DeNigris V , CerielloA. The “metabolic memory” theory and the early treatment of hyperglycemia in prevention of diabetic complications. Nutrients9(5), 437 (2017).
   PubMed Web of Science ®Google Scholar
• Drzewoski J , KasznickiJ , TrojanowskiZ. The role of “metabolic memory” in the natural history of diabetes mellitus. Pol. Arch. Med. Wewn.119(7–8), 493–500 (2009).
   PubMed Web of Science ®Google Scholar
• Intine RV , SarrasMPJr. Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms. Curr. Diab. Rep.12(5), 551–559 (2012).
   PubMed Web of Science ®Google Scholar
• Sharma S , BhondeR. Genetic and epigenetic stability of stem cells: epigenetic modifiers modulate the fate of mesenchymal stem cells. Genomics112(2020), 3615–3623 (2020).
   PubMedGoogle Scholar
• Chen MT , ZhaoYT , ZhouLYet al. Exosomes derived from human umbilical cord mesenchymal stem cells enhance insulin sensitivity in insulin resistant human adipocytes. Curr. Med. Sci.41(1), 87–93 (2021).
   PubMed Web of Science ®Google Scholar
• Hao Y , MiaoJ , LiuWet al. Mesenchymal stem cell-derived exosomes carry microRNA-125a to protect against diabetic nephropathy by targeting histone deacetylase 1 and downregulating endothelin-1. Diabetes Metab. Syndr. Obes.14, 1405–1418 (2021).
   PubMed Web of Science ®Google Scholar
• Zhang Y , LeX , ZhengSet al. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization. Stem Cell Res. Ther.13(1), 171 (2022).
   PubMed Web of Science ®Google Scholar
• Jin J , ShiY , GongJet al. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res. Ther.10(1), 95 (2019).
   PubMed Web of Science ®Google Scholar
• Jin J , WangY , ZhaoLet al. Exosomal miRNA-215-5p derived from adipose-derived stem cells attenuates epithelial–mesenchymal transition of podocytes by inhibiting ZEB2. Biomed. Res. Int.2020, 2685305 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang W , WangY , KongY. Exosomes derived from mesenchymal stem cells modulate miR-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting HMGB1. Invest. Ophthalmol. Vis. Sci.60(1), 294–303 (2019).
   PubMed Web of Science ®Google Scholar
• Zhao H , LiZ , WangYet al. Bioengineered MSC-derived exosomes in skin wound repair and regeneration. Front. Cell Dev. Biol.11, 1029671 (2023).
   PubMed Web of Science ®Google Scholar
• Zollner H , HahnSA , MaghnoujA. Lentiviral overexpression of miRNAs. Method Mol. Biol.1095, 177–190 (2014).
   PubMedGoogle Scholar
• Fan J , FengY , ZhangRet al. A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells. Cancer Gene Ther.27, 424–437 (2020).
   PubMed Web of Science ®Google Scholar